Back to top
more

Geron (GERN)

(Real Time Quote from BATS)

$1.52 USD

1.52
1,212,596

-0.01 (-0.65%)

Updated Aug 27, 2026 10:53 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Are Options Traders Betting on a Big Move in Geron (GERN) Stock?

by Zacks Equity Research

Investors in Geron (GERN) need to pay close attention to the stock based on moves in the options market lately.

    Zacks Equity Research

    Implied Volatility Surging for Geron (GERN) Stock Options

    by Zacks Equity Research

    Geron (GERN) needs investors to pay close attention to the stock based on moves in the options market lately.

      Zacks Equity Research

      Is Geron (GERN) Outperforming Other Medical Stocks This Year?

      by Zacks Equity Research

      Is Geron Corporation (GERN) Outperforming Other Medical Stocks This Year?

        Zacks Equity Research

        Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down

        by Zacks Equity Research

        Geron (GERN) beats earnings but on lower sales in Q1. Operating expenses were lower year over year.

          Zacks Equity Research

          What's in the Cards for Geron (GERN) This Earnings Season?

          by Zacks Equity Research

          With no approved product in Geron's (GERN) portfolio, investor focus continues to remain on its sole pipeline candidate, imetelstat, ahead of the first-quarter earnings release.

            Zacks Equity Research

            Is Geron Corporation (GERN) Stock Outpacing Its Medical Peers This Year?

            by Zacks Equity Research

            Is Geron Corporation (GERN) Outperforming Other Medical Stocks This Year?

              Zacks Equity Research

              Why Is Geron (GERN) Up 10.6% Since Its Last Earnings Report?

              by Zacks Equity Research

              Geron (GERN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                Zacks Equity Research

                Here's Why Geron Stock Surged More Than 90% in 6 Months

                by Zacks Equity Research

                Geron (GERN) telomerase inhibitor, imetelstat, is being evaluated in two late stage studies. The candidate is progressing well in the Janssen sponsored studies.

                  Zacks Equity Research

                  Geron (GERN) Q4 Loss Flat Y/Y, Revenues Surge, Shares Up

                  by Zacks Equity Research

                  Geron (GERN) misses earnings and sales estimates in Q4. However, revenues almost double year over year. Imetelstat remains in focus.

                    Zacks Equity Research

                    Geron (GERN) in Focus: Stock Moves 10.8% Higher

                    by Zacks Equity Research

                    Geron (GERN) was a big mover last session, as the company saw its shares rise nearly 11% on the day.